These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
598 related articles for article (PubMed ID: 29288412)
1. Closed-Loop Doluisio (Colon, Small Intestine) and Single-Pass Intestinal Perfusion (Colon, Jejunum) in Rat-Biophysical Model and Predictions Based on Caco-2. Lozoya-Agullo I; Gonzalez-Alvarez I; Zur M; Fine-Shamir N; Cohen Y; Markovic M; Garrigues TM; Dahan A; Gonzalez-Alvarez M; Merino-Sanjuán M; Bermejo M; Avdeef A Pharm Res; 2017 Dec; 35(1):2. PubMed ID: 29288412 [TBL] [Abstract][Full Text] [Related]
2. Investigating drug absorption from the colon: Single-pass vs. Doluisio approaches to in-situ rat large-intestinal perfusion. Lozoya-Agullo I; Zur M; Fine-Shamir N; Markovic M; Cohen Y; Porat D; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M; Dahan A Int J Pharm; 2017 Jul; 527(1-2):135-141. PubMed ID: 28501438 [TBL] [Abstract][Full Text] [Related]
3. Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon. Pade D; Jamei M; Rostami-Hodjegan A; Turner DB Biopharm Drug Dispos; 2017 Mar; 38(2):94-114. PubMed ID: 28214380 [TBL] [Abstract][Full Text] [Related]
4. In Situ Perfusion Model in Rat Colon for Drug Absorption Studies: Comparison with Small Intestine and Caco-2 Cell Model. Lozoya-Agullo I; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M J Pharm Sci; 2015 Sep; 104(9):3136-45. PubMed ID: 25891783 [TBL] [Abstract][Full Text] [Related]
5. Segmental-dependent permeability throughout the small intestine following oral drug administration: Single-pass vs. Doluisio approach to in-situ rat perfusion. Lozoya-Agullo I; Zur M; Beig A; Fine N; Cohen Y; González-Álvarez M; Merino-Sanjuán M; González-Álvarez I; Bermejo M; Dahan A Int J Pharm; 2016 Dec; 515(1-2):201-208. PubMed ID: 27667756 [TBL] [Abstract][Full Text] [Related]
6. In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches. Lozoya-Agullo I; Zur M; Wolk O; Beig A; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M; Dahan A Int J Pharm; 2015 Mar; 480(1-2):1-7. PubMed ID: 25595387 [TBL] [Abstract][Full Text] [Related]
7. Lamivudine permeability study: a comparison between PAMPA, ex vivo and in situ Single-Pass Intestinal Perfusion (SPIP) in rat jejunum. Reis JM; Dezani AB; Pereira TM; Avdeef A; Serra CH Eur J Pharm Sci; 2013 Mar; 48(4-5):781-9. PubMed ID: 23298578 [TBL] [Abstract][Full Text] [Related]
8. Regional Intestinal Permeability in Rats: A Comparison of Methods. Roos C; Dahlgren D; Sjögren E; Tannergren C; Abrahamsson B; Lennernäs H Mol Pharm; 2017 Dec; 14(12):4252-4261. PubMed ID: 28920690 [TBL] [Abstract][Full Text] [Related]
9. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat. Dahan A; West BT; Amidon GL Eur J Pharm Sci; 2009 Feb; 36(2-3):320-9. PubMed ID: 19028572 [TBL] [Abstract][Full Text] [Related]
10. How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability? Avdeef A; Tam KY J Med Chem; 2010 May; 53(9):3566-84. PubMed ID: 20373811 [TBL] [Abstract][Full Text] [Related]
11. Intestinal permeability of forskolin by in situ single pass perfusion in rats. Liu ZJ; Jiang DB; Tian LL; Yin JJ; Huang JM; Weng WY Planta Med; 2012 May; 78(7):698-702. PubMed ID: 22411728 [TBL] [Abstract][Full Text] [Related]
12. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting. Dahan A; Amidon GL Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926 [TBL] [Abstract][Full Text] [Related]
13. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting. Dahan A; Amidon GL Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137 [TBL] [Abstract][Full Text] [Related]
14. Rat intestinal drug permeability: A status report and summary of repeated determinations. Dubbelboer IR; Dahlgren D; Sjögren E; Lennernäs H Eur J Pharm Biopharm; 2019 Sep; 142():364-376. PubMed ID: 31283980 [TBL] [Abstract][Full Text] [Related]
15. Intestinal absorption of forsythoside A in in situ single-pass intestinal perfusion and in vitro Caco-2 cell models. Zhou W; Di LQ; Wang J; Shan JJ; Liu SJ; Ju WZ; Cai BC Acta Pharmacol Sin; 2012 Aug; 33(8):1069-79. PubMed ID: 22773077 [TBL] [Abstract][Full Text] [Related]
16. Intestinal absorption mechanisms of araloside A in situ single-pass intestinal perfusion and in vitro Caco-2 cell model. Yang H; Zhai B; Fan Y; Wang J; Sun J; Shi Y; Guo D Biomed Pharmacother; 2018 Oct; 106():1563-1569. PubMed ID: 30119231 [TBL] [Abstract][Full Text] [Related]
17. [The absorption characteristics of silybin in small intestine of rat]. Luan LB; Zhao N Yao Xue Xue Bao; 2006 Feb; 41(2):138-41. PubMed ID: 16671544 [TBL] [Abstract][Full Text] [Related]
18. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Dahan A; Amidon GL Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230 [TBL] [Abstract][Full Text] [Related]
19. Localisation of drug permeability along the rat small intestine, using markers of the paracellular, transcellular and some transporter routes. Lacombe O; Woodley J; Solleux C; Delbos JM; Boursier-Neyret C; Houin G Eur J Pharm Sci; 2004 Dec; 23(4-5):385-91. PubMed ID: 15567292 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of drug permeability calculation based on luminal disappearance and plasma appearance in the rat single-pass intestinal perfusion model. Dahlgren D; Roos C; Peters K; Lundqvist A; Tannergren C; Sjögren E; Sjöblom M; Lennernäs H Eur J Pharm Biopharm; 2019 Sep; 142():31-37. PubMed ID: 31201856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]